© 2014 • Sabin Vaccine Institute • 2000 Pennsylvania Ave, NW, Suite 7100 • Washington, DC 20006 • t. (202) 842-5025
Agenda of the 4th Mini Measles Rubella Symposium
Immunization is among the simplest, most cost-effective investments a nation can make to secure a healthy workforce, safeguard its population against devastating disease outbreaks and propel its economy into the next stage of development. However, national immunization budgets are currently insufficient to sustain the programs and incorporate new and costlier vaccines. The Sabin Vaccine Institute, through its Sustainable Immunization Financing (SIF) Program, works with country governments to secure long-term domestic financing for these programs.